Aramark reported third-quarter fiscal 2026 revenue of $5.1 billion, up 9% from a year earlier, with GAAP diluted EPS of $0.36, up 34%. The company raised its full-year organic revenue growth outlook to +9% to +10% and reaffirmed its adjusted operating income and adjusted EPS outlooks; the filing says a calendar shift from a 53rd week in the prior year reduced reported growth by an estimated 2%.
Q3 revenue rose 9% to $5.1 billion; organic revenue also rose 9%
GAAP diluted EPS was $0.36 versus $0.27 a year earlier; adjusted EPS was $0.52, up 29%
Full-year organic revenue growth outlook raised to +9% to +10%, from a prior high-end range of +7% to +9%
Adjusted operating income growth outlook of +12% to +17% and adjusted EPS growth outlook of +20% to +25% were reaffirmed
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Aramark's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$18.51B
+6.4%
$1.22
+23.2%
1.8%
FY2024
$17.40B
+8.2%
$0.99
-61.5%
1.5%
FY2023
$16.08B
+17.5%
$2.57
+242.7%
4.2%
FY2022
$13.69B
+13.2%
$0.75
—
1.4%
FY2021
$12.10B
-5.7%
$-0.36
—
-0.8%
Frequently asked questions
When is Aramark's next earnings date?
Aramark (ARMK) is scheduled to report on Monday, November 16, 2026 before the market opens. Analysts expect EPS of $0.75.
What did Aramark earn last quarter?
For the quarter ended Jul 2026, Aramark reported diluted EPS of $0.36 (+33.3% year over year) on revenue of $5.06B (+9.3%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.